XML 40 R13.htm IDEA: XBRL DOCUMENT v2.4.1.9
STOCKHOLDERS' EQUITY
 6 Months Ended
Dec. 31, 2014
STOCKHOLDERS' EQUITY [Abstract]  
STOCKHOLDERS' EQUITY

NOTE 6: - STOCKHOLDERS' EQUITY

a. From July 2014 through December 2014, a total of 1,449,010 warrants were exercised via “cashless” exercise, resulting in the issuance of 675,067 shares of common stock to investors of the Company.  In addition, 147,667 warrants were exercised for cash and resulted in the issuance of 147,667 shares of common stock to investors of the Company. The aggregate cash consideration received was $244.
 
b. In October 2014, the Company issued 200,000 shares of common stock to an investor, in a private placement. The aggregate cash consideration received was $528.
 
c. In December 2014, the Company issued 100,004 restricted stocks to its new laboratories facility contractor. The restricted stocks are linked to performance milestones with respect to the building of new laboratories in the Company's rented facility. These milestones have not been met yet. The fair value of the restricted stocks as of December 31, 2014 amounted to approximately $250.
 
d. Options, warrants and restricted stock units to employees, directors and consultants:

1. Options to employees and directors:

           A summary of the Company's activity related to options granted to employees and directors under the Company's 2003 and 2005 option plans is as follows:

  Six months ended December 31, 2014 (Unaudited)
Number       Weighted Average
Exercise Price		   Weighted Average
Remaining
Contractual Terms
(in years)		     Aggregate Intrinsic
Value Price
Options outstanding at beginning of period 1,862,099     $ 3.73          
Options exercised (3,000 )   $ 0.62          
Options forfeited -                  
Options outstanding at end of the period 1,859,099     $ 3.73   2.62   $ 778
Options exercisable at the end of the period 1,859,099     $ 3.73   2.62   $ 778
Options vested 1,859,099     $ 3.73   2.62   $ 778
 
Intrinsic value of exercisable options (the difference between the Company's closing stock price on the last trading day in the period and the exercise price, multiplied by the number of in-the-money options) represents the amount that would have been received by the employees and directors option holders had all option holders exercised their options on December 31, 2014. This amount changes based on the fair market value of the Company's common stock.
 
2. Options and warrants to non-employees:

           A summary of the activity related to options and warrants to consultants is as follows:

            During the six month period ended December 31, 2014, there were no grants, exercises or forfeitures of options and warrants to or by non-employees consultants.

Six months ended December 31, 2014 (Unaudited)
Number       Weighted Average
Exercise Price		   Weighted Average
Remaining
Contractual Terms
(in years)		     Aggregate Intrinsic 
Value
Price
Options and warrants outstanding at beginning of period 252,000     $ 5.19          
Options and warrants outstanding at end of the period 252,000     $ 5.19   3.45   $ 262
                     
Options and warrants exercisable at the end of the period 252,000     $ 5.19   3.45   $ 262
                     
Options and warrants vested and expected to vest 252,000     $ 5.19   3.45   $ 262

            Compensation expenses related to options and warrants granted to consultants were recorded as follows:

Six months ended December 31, Three months ended December 31,
2014 2013 2014 2013
Research and development expenses   $ 1     $ 2   $          -   $             -
General and administrative expenses     -       -     -     -
    $ 1     $ 2   $          -    $             -
 
3. Restricted stock units to employees and directors:

           During the six month period ended December 31, 2014, the Company granted restricted stock units to several of the Company's employees and directors.

           The following table summarizes the activity related to unvested restricted stock units granted to employees and directors for the six-month period ended December 31, 2014 (Unaudited):

  Number  
Unvested at the beginning of period 1,589,432  
Granted 33,619  
Forfeited (18,405 )
Vested (722,243 )
Unvested at the end of the period 882,403  
Expected to vest after  December 31, 2014 863,706  

           Compensation expenses related to restricted stock units granted to employees and directors were recorded as follows:

Six months ended 
December 31,		 Three months ended 
December 31,
     2014      2013      2014    2013
Research and development expenses   $ 495     $ 214     $ 162   $ 88
General and administrative expenses     1,143       2,103       441     1,055
    $ 1,638     $ 2,317     $ 603   $ 1,143

            Unamortized compensation expenses related to restricted stock units granted to employees and directors to be recognized over an average time of approximately 2 years is $870.

4. Restricted stock units to consultants:
                
           During the six month period ended December 31, 2014, the Company granted restricted stock units to several consultants and service providers.

            The following table summarizes the activity related to unvested restricted stock units granted to consultants for the six months ended December 31, 2014:

  Number  
Unvested at the beginning of period 15,250  
Granted 50,180  
Forfeited -  
Vested (45,430 )
Unvested at the end of the period 20,000  
Expected to vest after December 31, 2014 20,000  

               Compensation expenses related to restricted stock units granted to consultants were recorded as follows:

Six months ended December 31, Three months ended December 31,
2014 2013 2014 2013
Research and development expenses   $ 77     $ 17     $ 57   $ 16
General and administrative expenses     38       -       34   - 
    $ 115     $ 17     $ 91   $ 16